TOHEEB OLALEKAN Toheeb

Mr. TOHEEB OLALEKAN Toheeb

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2025 in Neuroglia
Verified
Journal Article
Open access
PDF file
OIOlayemi Kafilat Ijomone
Olayemi Kafilat Ijomone
IUIleje Inelo Ukwubile
Ileje Inelo Ukwubile
OAOluoma Vivian Aneke
Oluoma Vivian Aneke
TOTobiloba S Olajide
Tobiloba S Olajide
HIHappiness Ochi Inyang
Happiness Ochi Inyang
OIOmamuyovwi Ijomone
Omamuyovwi Ijomone
Overexposure of humans to heavy metals and essential metals poses a significant risk for the development of neurological and neurodevelopmental disorders. The mechanisms through which these metals exert their effects include the generation of reactive oxygen species, mitochondrial dysfunction, activation of inflammatory pathways, and disruption of cellular signaling. The function of glial cells in brain development and in the maintenance of homeostasis cannot be overlooked. The glial cells are particularly susceptible to metal-induced neurotoxicity. Accumulation of metals in the brain promotes microglial activation, triggering inflammatory responses that can coincide with other mechanisms of neurotoxicity, inducing alteration in synaptic transmission, cognitive deficit, and neuronal damage. In this review, we highlighted the role of glial dysfunction in some selected neurodegenerative diseases and neurodevelopmental disorders. We further dive into how exposure to metals such as nickel, manganese, methyl mercury, cadmium, iron, arsenic, and lead affect the functions of the microglia, astrocytes, and oligodendrocytes and the mechanisms through which they exert the effects on the brain in relation to some selected neurodegenerative diseases and neurodevelopmental disorders. Potential therapeutic interventions such as the use of new and improved chelating agents and antioxidant therapies might be a significant approach to alleviating these metal-induced glial perturbations.

15 September 2024 in Neuroprotection
Verified
Journal Article
Open access
TOTobiloba S Olajide
Tobiloba S Olajide
TTTOHEEB OLALEKAN Toheeb
TOHEEB OLALEKAN Toheeb
OOOmolabake Ifeoluwa Omotosho
Omolabake Ifeoluwa Omotosho
Oritoke OkeowoOritoke Okeowo
Oritoke Okeowo
OOOlayemi Joseph Olajide
Olayemi Joseph Olajide
OIOmamuyovwi Ijomone
Omamuyovwi Ijomone
The existing literature on neurodegenerative diseases (NDDs) reveals a common pathological feature: the accumulation of misfolded proteins. However, the heterogeneity in disease onset mechanisms and the specific brain regions affected complicates the understanding of the diverse clinical manifestations of individual NDDs. Dementia, a hallmark symptom across various NDDs, serves as a multifaceted denominator, contributing to the clinical manifestations of these disorders. There is a compelling hypothesis that therapeutic strategies capable of mitigating misfolded protein accumulation and disrupting ongoing pathogenic processes may slow or even halt disease progression. Recent research has linked disease‐associated microglia to their transition into a senescent state—characterized by irreversible cell cycle arrest—in aging populations and NDDs. Although senescent microglia are consistently observed in NDDs, few studies have utilized animal models to explore their role in disease pathology. Emerging evidence from experimental rat models suggests that disease‐associated microglia exhibit characteristics of senescence, indicating that deeper exploration of microglial senescence could enhance our understanding of NDD pathogenesis and reveal novel therapeutic targets. This review underscores the importance of investigating microglial senescence and its potential contributions to the pathophysiology of NDDs, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. Additionally, it highlights the potential of targeting microglial senescence through iron chelation and senolytic therapies as innovative approaches for treating age‐related NDDs.

28 August 2024
Verified
Book Chapter
Closed access
PDF file
AAAbraham Olufemi Asuku
Abraham Olufemi Asuku
MAMaryam Tayo Ayinla
Maryam Tayo Ayinla
OGOyinlola Ogungbangbe Gbonjubola
Oyinlola Ogungbangbe Gbonjubola
SBSaliu Salam Babatunde
Saliu Salam Babatunde
TOTobiloba S Olajide
Tobiloba S Olajide
TTTOHEEB OLALEKAN Toheeb
TOHEEB OLALEKAN Toheeb

10 January 2025
Verified
Book Chapter
Closed access
AAAbraham Olufemi Asuku
Abraham Olufemi Asuku
EAEmmanuel Sunday Arinde
Emmanuel Sunday Arinde
SSSalam Babatunde Saliu
Salam Babatunde Saliu
TTTOHEEB OLALEKAN Toheeb
TOHEEB OLALEKAN Toheeb
TOTobiloba S Olajide
Tobiloba S Olajide
AKAfeez Kehinde
Afeez Kehinde
An overview of the complex idea of neuroplasticity and its applications to recovery and rehabilitation is given in this chapter. The chapter explores the fundamentals of neuroplasticity, explaining structural and synaptic plasticity as well as important mechanisms like long-term depression (LTD) and long-term potentiation (LTP). Applications in neurorehabilitation are addressed. In the framework of neuroplasticity, cognitive training techniques such as memory improvement and skill development are covered. The effects of lifestyle variables that affect neuroplasticity—such as sleep, diet, and exercise—on brain activity are investigated. The chapter highlights the possible future avenues in neuroplasticity research while acknowledging limitations such as individual heterogeneity and ethical constraints. It concludes by highlighting the neuroplasticity's transformative potential and advocating for further research, implementation, and integration into therapeutic procedures to promote cognitive function and promote healing.

25 October 2024
Verified
Book Chapter
Closed access
AAAbraham Olufemi Asuku
Abraham Olufemi Asuku
AAAyodeji Johnson Ajibare
Ayodeji Johnson Ajibare
EAEbele Joan Ajagun
Ebele Joan Ajagun
SBSaliu Salam Babatunde
Saliu Salam Babatunde
TOTobiloba S Olajide
Tobiloba S Olajide
OOOlawunmi Anthonia Odugbesan
Olawunmi Anthonia Odugbesan
This chapter discusses natural compounds recognized for their antiaging properties and describes the underlying mechanisms of action, providing a concise synopsis of studies on the efficacy of herbal extracts in antiaging products. The potential of certain herbal extracts, such as green tea, ginkgo, licorice, Aloe vera, and ginseng, in treating various signs of aging has been investigated in response to the growing demand for natural alternatives. Their mechanisms of action, which primarily target antioxidant defense, collagen production, and cellular repair, explain how they reduce oxidative stress, improve skin elasticity, and promote cellular rejuvenation. The chapter then discusses future trends and issues and proposes potential solutions.

4 November 2025 in Ibrain
Verified
Journal Article
Open access
TTTOHEEB OLALEKAN Toheeb
TOHEEB OLALEKAN Toheeb
VAVictor E. Anadu
Victor E. Anadu
TOTobiloba S Olajide
Tobiloba S Olajide
IUIleje I. Ukwubile
Ileje I. Ukwubile
OIOlayemi K. Ijomone
Olayemi K. Ijomone
OIOmamuyovwi Ijomone
Omamuyovwi Ijomone
Synaptic adhesion molecules (SAMs) are glycoproteins localized on neuronal surfaces, primarily expressed at synaptic plasma membranes. SAMs play a role in inducing formation, maturation, plasticity, and assembly of synaptic connections, which are vital for normal neurodevelopment. SAMs link the pre‐ and post‐synaptic compartments and assist in inter‐synaptic signaling and recognition. An increasing variety of SAMs, including neurexins and neuroligins, immunoglobulin (Ig) domain proteins‐like synaptic cell adhesion molecule (SynCAM) and neural cell adhesion molecule, receptor phosphotyrosine kinases and phosphatases, as well as various leucine‐rich repeat proteins, have been identified. Neurodevelopmental disorders (NDDs), like autism, attention deficit hyperactivity disorder, intellectual disabilities, and cerebral palsy, have been associated with altered SAMs. NDDs are characterized by a spectrum of challenges stemming from abnormal brain development. The etiology of these disorders involves the interaction between genes and environmental factors, such as metals. This review aims to provide a comprehensive overview of the literature, highlighting the role of SAMs in NDDs and potential mechanisms via which neurotoxic metals may contribute to the pathogenesis of NDDs that could involve perturbations in SAMs. Understanding these interconnections will assist in identifying therapeutic targets for these disorders.